Table 2.
Classification of severity and duration of the infection in Covid-19 patients by intervention group.
| All Patients (n = 19) |
Control Group (n = 8) |
Probiotic Group (n = 11) |
p between-Groups | ||
|---|---|---|---|---|---|
| Classification of severity | 0.189 | ||||
| Asymptomatic Infection | n (%) | 5 (26.3%) | 1 (12.5%) | 4 (36.4%) | |
| Mild Illness | n (%) | 3 (15.8%) | 2 (25%) | 1 (9.1%) | |
| Moderate Illness | n (%) | 2 (10.5%) | 1 (12.5%) | 1 (9.1%) | |
| Severe Illness | n (%) | 7 (36.8%) | 3 (37.5%) | 4 (36.4%) | |
| Critical Illness | n (%) | 2 (10.5%) | 1 (12.5%) | 1 (9.1%) | |
| Time to symptom resolution (days) 1 | Mean ± SD | 7.47 ± 1.79 | 6.13 ± 4.22 | 8.45 ± 9.69 | 0.587 |
Values are mean ± SD for continuous variables and n (%) for categorical variables. p indicates differences between the control group and the probiotic group (ordinal logistic regression test for the categorical variable and univariate test for continuous variable) adjusted by age, sex, and the disease index1. Time to symptom resolution was calculated in volunteers that survived (n = 7 in the control group and n = 10 in the probiotic group).